Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bi Cheng Wang

Showing results (11-20 of 139) with videos related to

Pageof 14
Sort By:
Targeted Oncology|January 30, 2024
Lenvatinib Versus Atezolizumab Plus Bevacizumab in the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Meta-Analysis of Real-World StudiesBi-Cheng Wang, Bo-Hua Kuang, Guo-He Lin
Clinical Nuclear Medicine|February 24, 2015
Dual-phase 99mTc-MIBI imaging findings in sporadic primary hyperplasia of parathyroid glandsQi-Sheng Yang, Chang-Yin Wang, Bi-Cheng Wang
Medicine|November 26, 2019
Efficacy and safety of anti-PD-1/PD-L1 agents vs chemotherapy in patients with gastric or gastroesophageal junction cancer: a systematic review and meta-analysisBi-Cheng Wang, Zhan-Jie Zhang, Chen Fu, et al.
Cancer Medicine|August 23, 2019
The effects and safety of PD-1/PD-L1 inhibitors on head and neck cancer: A systematic review and meta-analysisBi-Cheng Wang, Ru-Bo Cao, Pin-Dong Li, et al.
RNA (New York, N.Y.)|May 29, 2010
Single amino acid changes in the predicted RNase H domain of Escherichia coli RNase G lead to complementation of RNase E deletion mutantsDae-hwan Chung, Zhao Min, Bi-Cheng Wang, et al.
Frontiers in Immunology|January 7, 2025
Durvalumab and pembrolizumab in advanced biliary tract cancer: a reconstructed patient-level mimic head-to-head comparative analysisBi-Cheng Wang, Bo-Hua Kuang, Guo-He Lin, et al.
Journal of Oncology|August 23, 2022
UHRF1 Induces Metastasis in Thyroid CancerBo-Hua Kuang, Guo-He Lin, Quentin Liu, et al.
Annals of Palliative Medicine|June 25, 2020
Efficacy and safety of gemcitabine plus capecitabine in the treatment of advanced or metastatic pancreatic cancer: a systematic review and meta-analysisBo-Ya Xiao, Bi-Cheng Wang, Guo-He Lin, et al.
Frontiers in Oncology|December 9, 2021
Doxorubicin/Adriamycin Monotherapy or Plus Ifosfamide in First-Line Treatment for Advanced Soft Tissue Sarcoma: A Pooled Analysis of Randomized TrialsBi-Cheng Wang, Bo-Hua Kuang, Bo-Ya Xiao, et al.
Frontiers in Endocrinology|July 11, 2024
Emerging chemotherapy-based treatments in anaplastic thyroid cancer: an updated analysis of prospective studiesBi-Cheng Wang, Guo-He Lin, Bo-Hua Kuang, et al.
Pageof 14

Showing results (11-20 of 139) with videos related to

Sort By:
Pageof 14
Targeted Oncology|January 30, 2024
Lenvatinib Versus Atezolizumab Plus Bevacizumab in the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Meta-Analysis of Real-World StudiesBi-Cheng Wang, Bo-Hua Kuang, Guo-He Lin
Clinical Nuclear Medicine|February 24, 2015
Dual-phase 99mTc-MIBI imaging findings in sporadic primary hyperplasia of parathyroid glandsQi-Sheng Yang, Chang-Yin Wang, Bi-Cheng Wang
Medicine|November 26, 2019
Efficacy and safety of anti-PD-1/PD-L1 agents vs chemotherapy in patients with gastric or gastroesophageal junction cancer: a systematic review and meta-analysisBi-Cheng Wang, Zhan-Jie Zhang, Chen Fu, et al.
Cancer Medicine|August 23, 2019
The effects and safety of PD-1/PD-L1 inhibitors on head and neck cancer: A systematic review and meta-analysisBi-Cheng Wang, Ru-Bo Cao, Pin-Dong Li, et al.
RNA (New York, N.Y.)|May 29, 2010
Single amino acid changes in the predicted RNase H domain of Escherichia coli RNase G lead to complementation of RNase E deletion mutantsDae-hwan Chung, Zhao Min, Bi-Cheng Wang, et al.
Frontiers in Immunology|January 7, 2025
Durvalumab and pembrolizumab in advanced biliary tract cancer: a reconstructed patient-level mimic head-to-head comparative analysisBi-Cheng Wang, Bo-Hua Kuang, Guo-He Lin, et al.
Journal of Oncology|August 23, 2022
UHRF1 Induces Metastasis in Thyroid CancerBo-Hua Kuang, Guo-He Lin, Quentin Liu, et al.
Annals of Palliative Medicine|June 25, 2020
Efficacy and safety of gemcitabine plus capecitabine in the treatment of advanced or metastatic pancreatic cancer: a systematic review and meta-analysisBo-Ya Xiao, Bi-Cheng Wang, Guo-He Lin, et al.
Frontiers in Oncology|December 9, 2021
Doxorubicin/Adriamycin Monotherapy or Plus Ifosfamide in First-Line Treatment for Advanced Soft Tissue Sarcoma: A Pooled Analysis of Randomized TrialsBi-Cheng Wang, Bo-Hua Kuang, Bo-Ya Xiao, et al.
Frontiers in Endocrinology|July 11, 2024
Emerging chemotherapy-based treatments in anaplastic thyroid cancer: an updated analysis of prospective studiesBi-Cheng Wang, Guo-He Lin, Bo-Hua Kuang, et al.
Pageof 14